ArticleJournal of cell communication and signaling2026

Gemcitabine activates the Hippo signaling pathway and suppresses tumor growth by stabilizing large tumor suppressor kinase 2 through the hypoxia-inducible factor 1-alpha/ubiquitin protein ligase E3 component N-recognin 5 axis.

Jin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.